However, the requirement of B cell-produced CCL3 in RA pathogenesis and bone loss merits further examination in mice carrying the B cell-specific knockout of CCL3 or OB-specific or mesenchymal precursor-specific knockout of CCR1/CCR5, receptors for CCL3. This evidence concerns the gene CCL3 and rheumatoid arthritis.